We serve Chemical Name:2-(2-chloro-4-fluorophenyl)acetamide CAS:306937-35-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(2-chloro-4-fluorophenyl)acetamide
CAS.NO:306937-35-9
Synonyms:2-(2-chloro-4-fluorophenyl)acetamide
Molecular Formula:C8H7ClFNO
Molecular Weight:187.59900
HS Code:2924299090
Physical and Chemical Properties:
Melting point:171ºC
Boiling point:342.7ºC at 760mmHg
Density:1.347g/cm3
Index of Refraction:1.548
PSA:43.09000
Exact Mass:187.02000
LogP:2.20720
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(2-chloro-4-fluorophenyl)acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2-chloro-4-fluorophenyl)acetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2-chloro-4-fluorophenyl)acetamide Use and application,2-(2-chloro-4-fluorophenyl)acetamide technical grade,usp/ep/jp grade.
Related News: As part of the deal, CROS NT CEO Paolo Morelli becomes Alira’s executive vice president of biometrics. 2-(2-chloro-4-fluorophenyl)acetamide manufacturer As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 2-(2-chloro-4-fluorophenyl)acetamide supplier As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 2-(2-chloro-4-fluorophenyl)acetamide vendor As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 2-(2-chloro-4-fluorophenyl)acetamide factory As part of the deal, CROS NT CEO Paolo Morelli becomes Alira’s executive vice president of biometrics.
